anx_I__cpt_1__cpt_2__cpt_7__list_2
the continuation of the European & Developing Countries Clinical Trials Partnership (EDCTP2) on clinical trials for medical interventions against HIV, malaria, tuberculosis and neglected diseases; support by way of an annual subscription to the Human Frontier Science Programme (HFSP) to allow non-G7 Member States to fully benefit from the funding provided by the HFSP; international consortium on rare diseases, with a number of Member States and third countries. The aim of this initiative is to develop by 2020 diagnostic tests for most rare diseases and 200 new therapies for rare diseases; support to the activities of the International Knowledge-Based Bio-Economy Forum and the EU-US Task Force on Biotechnology Research as well as collaborative links with relevant international organisations and initiatives, such as global research alliances on agricultural greenhouse gases and on animal health; contribution to multilateral processes and initiatives, such as the Intergovernmental Panel on Climate Change (IPCC), the Intergovernmental Platform on Biodiversity and Ecosystem Services (IPBES), and the Group on Earth Observations (GEO); the Space Dialogues between the Union and the United States and Russia, the two major space faring nations, is an extremely valuable one and forms the basis for the establishment of strategic cooperation in space partnerships; the implementing arrangement between the Union and the United States for cooperative activities in the field of Homeland Security/Civil Security/Research, signed on 18 November 2010; cooperation with developing countries, including from Sub-Saharan Africa, in the field of decentralised energy production for poverty alleviation; continuation of research collaboration with Brazil on new generation of biofuels and other uses of biomass.
← anx_I__cpt_1__cpt_2__cpt_7__text_7 · All articles · (a) →
Source: EUR-Lex (Cellar) · retrieved 2026-11-04 · Text as adopted (Official Journal); later amendments are not incorporated in this text.